Lower riskMedical device recall · FDA · Published September 22, 2026
Xact Mole Marker Recall: Radiopaque Material May Detach
Solstice Corporation recalls Xact Mole Marker Model M15RM for potential detachment of radiopaque material causing mammography artifacts. Affected units sold worldwide in US states and Canada.
“Xact Mole Marker Recall: Radiopaque Material May Detach.” GovInfoNow, updated November 11, 2026. https://govinfonow.com/recall/1932663-solstice-corporation-recalls-xact-mole-marker-for-mammography-model-catalog. Based on FDA recall #Z-0268-2027 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0268-2027%22&limit=1).
The FDA announced on September 22, 2026, that Solstice Corporation is recalling the Xact Mole Marker for mammography (Model/Catalog Number M15RM). The radiopaque material may detach from the marker, potentially causing artifacts. This voluntary Class II recall affects 736 units distributed in the U.S., Canada, and Puerto Rico.
How to tell if you have it
Brand: Solstice Corporation
Product: Xact Mole Marker
Model/Catalog Number: M15RM
Part #: M15RM
UDI-DI: 00854623006068
UPC-A
Lot #: M15RM26A
The hazard
The radiopaque material may detach from the marker. In some cases, artifact was noted and attributed to the detached material.
Context
GovInfoNow's records show other recent recalls of similar products include Hologic SELENIA Dimensions Mammography Systems Recall (2026-04-08), GE Optima XR200amx Mobile Radiography System Recall (2026-06-05), and HydroMARK Breast Biopsy Marker Recall (2026-04-24).
How to tell if you have this one
Check for the model number M15RM on the marker or packaging. The product was sold with UPC-A and lot number M15RM26A in the US states and Canada.
Brand
Solstice Corporation
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Check Product Details
Look for the model number M15RM on the marker or packaging to confirm if it's affected.
Where it went and when
Where it was distributed
Distributed nationwide and abroad; the notice names 11 states.
Named in the notice
Covered by “nationwide”
Not listed
FDA distribution: “Worldwide - US Nationwide distribution in the states and territory of CA, FL, IL, IN, MN, MO, NY, OH, PA, TX, WV and Puerto Rico. The country of Canada.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: California, Florida, Illinois, Indiana, Minnesota, Missouri, New York, Ohio, Pennsylvania, Puerto Rico, Texas, West Virginia.
Recall timeline
FDA published this recall 36 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4Added to GovInfoNow
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-0268-2027 (September 22, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0268-2027 to see it in context.
Plain-language summary written by qwen3:4b on November 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.